VOLITIONRX LTD
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 13, 2026
VNRX$0.20+2.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. EXHIBITS
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| Exhibit Number | Exhibit Description | Form | File No. | Exhibit | Filing Date | Filed Herewith |
| 1.1 | Placement Agency Agreement, dated June 7, 2026, by and between VolitionRx Limited and Maxim Group LLC | 8-K | 001-36833 | 1.1 | 6/10/26 | |
| 3.1 | Second Amended and Restated Certificate of Incorporation, as amended. | S-3 | 333-288508 | 3.1 | 7/3/25 | |
| 3.2 | Certificate of Third Amendment of the Second Amended and Restated Certificate of Incorporation. | 8-K | 001-36833 | 3.1 | 4/28/26 | |
| 3.3 | Certificate of Fourth Amendment of the Second Amended and Restated Certificate of Incorporation | X | ||||
| 3.4 | Amended and Restated Bylaws, as amended and currently in effect. | 10-Q | 001-36833 | 3.2 | 5/13/24 | |
| 4.1 | Description of Capital Stock. | X | ||||
| 4.2 | Form of Warrant | 8-K | 001-36833 | 4.1 | 6/10/26 | |
| 4.3 | Warrant Agent Agreement, dated June 9, 2026, by and between VolitionRx Limited and VStock Transfer, LLC | 8-K | 001-36833 | 4.2 | 6/10/26 | |
| 10.1 | Form of Securities Purchase Agreement, dated as of June 7, 2026, by and among VolitionRx Limited and the purchasers on the signature pages thereto | 8-K | 001-36833 | 10.1 | 6/10/26 | |
| 10.2 | Waiver and Consent, dated as of May 21, 2026, by and between VolitionRx Limited and Lind Global Asset Management XII LLC | X | ||||
| 10.3 | 2026 Stock Incentive Plan | X | ||||
| 10.4 | Notice of Restricted Stock Award | X | ||||
| 10.5 | Notice of Restricted Stock Unit Award | X | ||||
| 10.6 | Notice of Stock Appreciation Right Award | X | ||||
| 10.7 | Notice of Stock Option Grant | X | ||||
| 10.8 | Notice of Performance Shares Award | X | ||||
| 10.9 | Notice of Stock Bonus Award | X | ||||
| 31.1* | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended. | X | ||||
| 31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended. | X | ||||
| 32.1* | Certifications of Chief Executive Officer and Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 101.INS | Inline XBRL Instance Document. | X | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. | X | ||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | X | ||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | X | ||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | X | ||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | X | ||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | X | ||||
| * | The certifications attached as Exhibit 32.1 accompany this Report pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed “filed” by the registrant for purposes of Section 18 of the Exchange Act and are not to be incorporated by reference into any of the registrant’s filings under the Securities Act or the Exchange Act, irrespective of any general incorporation language contained in any such filing. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.